APO enters its June 8 earnings release with the most call-heavy options positioning in at least a year — yet the stock has slipped quietly and insiders have been selling into the pre-print strength.
The options signal is the sharpest data point right now. The put/call ratio fell to 0.83 on June 5, more than three standard deviations below its 20-day average of 0.88, making it the most bullish options read in at least twelve months. That is a notable move from late April, when the PCR was running near 0.92. Call demand has built steadily and accelerated into the final sessions before results. This is not a marginal tilt — the z-score of -3.45 puts it in rare territory.
Short positioning tells a quieter but consistent story. Short interest has eased to 5.3% of the free float, down roughly 1.3% over the week and nearly 3% over the past month — the bears who built through mid-May have continued to pull back. Borrow conditions offer no friction to that retreat: availability is running at 232%, meaning more than twice as many shares remain available to lend as are currently borrowed. Cost to borrow has crept up 13% over the week to 0.54% annually, but that still ranks as low in absolute terms. The lending market is loose, short interest is trimming, and options traders are leaning hard into calls — three signals pointing the same direction.
The Street broadly backs that setup. Analysts carry a consensus price target of $150.25 against a closing price of $128.03, implying roughly 17% upside. Most recent analyst activity reinforced that view: Piper Sandler raised its target to $157 earlier this week while maintaining Overweight, and UBS lifted to $158 following the last earnings print. The one exception was TD Cowen, which trimmed to $146 from $155 while holding Buy — a signal of recalibration rather than conviction change. The ORTEX short score sits at 60, elevated but stable, consistent with a mid-sized short base rather than an aggressive crowded short. The forward EPS growth rank is strong at the 88th percentile, though the EPS surprise factor score of just 4 is a reminder that APO has not consistently beaten the number on print day.
The insider picture complicates the bullish setup. Apollo's subsidiary president John Zito sold just over $6.4 million across three transactions on May 27, with CFO Martin Kelly selling an additional $943,000 on May 14. Net insider sales over the past 90 days total approximately $7.3 million. These are not distress signals — executive pre-arranged selling is routine — but the timing, right before a quarterly print, is worth noting against the backdrop of call-heavy positioning.
The last quarterly print produced a 1.9% decline on the day before recovering fully over the following week, a pattern suggesting the market has historically bought the dip after initial disappointment. The June 8 release — scheduled for 4pm Eastern — is the next thing to watch: specifically whether management updates deployment guidance and commentary on the retirement services inflow trajectory, which has been the central bull thesis.
See the live data behind this article on ORTEX.
Open APO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
